BRAIN Biotech AG (BNN)
XETR
2.76
-0.13 (-4.50%)
Closed
Oct 7, 2026
Day's Range
2.762.89
52 wk Range
2.053.74
Financial Statements - BNN - BRAIN Biotech AG
Revenue
50.01M▼ 8.4%
Net Income
-11.83M▼ 6.6%Net Margin -23.7%
EBITDA
-6.12M▼ 31.8%
Free Cash Flow
-10.83M▼ 104.0%
Income Statement
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|---|
| Sales | 50.01M | 54.63M | 55.33M | 49.50M | 38.38M | 38.22M |
| Cost of Goods | 21.37M | 24.30M | 25.21M | 22.06M | 16.81M | 17.02M |
| Gross Profit | 28.63M | 30.32M | 30.12M | 27.44M | 21.57M | 21.20M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -7.44M | -9.15M | -5.95M | -6.73M | -7.55M | -8.04M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -12.02M | -10.99M | -7.48M | -6.16M | -4.27M | -9.94M |
| Income Tax | -191K | 111K | 625K | 176K | 403K | -927K |
| Net Income | -11.83M | -11.10M | -8.11M | -6.34M | -4.68M | -9.01M |
| EPS Basic | -0.54 | -0.51 | -0.38 | -0.3 | -0.25 | -0.52 |
| EPS Diluted | -0.54 | -0.51 | -0.38 | -0.3 | -0.25 | -0.52 |
| Basic Shares Outstanding | 21.84M | 21.84M | 21.84M | 21.84M | 19.94M | 18.65M |
| Diluted Shares Outstanding | 21.84M | 21.84M | 21.84M | 21.84M | 19.94M | 18.65M |
| Ebit | -9.81M | -9.05M | -6.63M | -5.63M | -3.75M | -9.27M |
| Ebitda | -6.12M | -4.64M | -2.41M | -4.52M | -5.08M | -5.48M |
| Net Income Continuous Operations | -11.83M | -11.10M | -8.11M | -6.34M | -4.68M | -9.01M |
| Minority Interests | 91K | -27K | -165K | -249K | -292K | -667K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
